Cargando…
EPHX2 Inhibits Colon Cancer Progression by Promoting Fatty Acid Degradation
Tumor cells use metabolic reprogramming to keep up with the need for bioenergy, biosynthesis, and oxidation balance needed for rapid tumor division. This phenomenon is considered a marker of tumors, including colon cancer (CRC). As an important pathway of cellular energy metabolism, fatty acid metab...
Autores principales: | Zhou, Yiran, Li, Xiao, Guan, Aoran, Zhou, Haodong, Zhu, Yankun, Wang, Ruotian, Li, Ruhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005964/ https://www.ncbi.nlm.nih.gov/pubmed/35433439 http://dx.doi.org/10.3389/fonc.2022.870721 |
Ejemplares similares
-
Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
por: Zhou, Yiran, et al.
Publicado: (2021) -
Impact of cytotoxic T lymphocytes immunotherapy on prognosis of colorectal cancer patients
por: Zhu, Yankun, et al.
Publicado: (2023) -
microRNA-130a is an oncomir suppressing the expression of CRMP4 in gastric cancer
por: Zhou, Yiran, et al.
Publicado: (2017) -
Clinical significance of EPHX2 deregulation in prostate cancer
por: Liu, Ming-Sheng, et al.
Publicado: (2020) -
LncRNA DNAJC3-AS1 Regulates Fatty Acid Synthase via the EGFR Pathway to Promote the Progression of Colorectal Cancer
por: Tang, Yanyan, et al.
Publicado: (2021)